128 related articles for article (PubMed ID: 10347889)
1. Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays.
Galvin M; Hill C; Ross RP
Lett Appl Microbiol; 1999 May; 28(5):355-8. PubMed ID: 10347889
[TBL] [Abstract][Full Text] [Related]
2. Development of a lacticin 3147-enriched whey powder with inhibitory activity against foodborne pathogens.
Morgan SM; Galvin M; Kelly J; Ross RP; Hill C
J Food Prot; 1999 Sep; 62(9):1011-6. PubMed ID: 10492475
[TBL] [Abstract][Full Text] [Related]
3. Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14.
Iwatani S; Zendo T; Yoneyama F; Nakayama J; Sonomoto K
Biosci Biotechnol Biochem; 2007 Aug; 71(8):1984-92. PubMed ID: 17690480
[TBL] [Abstract][Full Text] [Related]
4. Heterologous expression of lacticin 3147 in Enterococcus faecalis: comparison of biological activity with cytolysin.
Ryan MP; McAuliffe O; Ross RP; Hill C
Lett Appl Microbiol; 2001 Feb; 32(2):71-7. PubMed ID: 11169046
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a spray-dried lacticin 3147 powder for the control of Listeria monocytogenes and Bacillus cereus in a range of food systems.
Morgan SM; Galvin M; Ross RP; Hill C
Lett Appl Microbiol; 2001 Nov; 33(5):387-91. PubMed ID: 11696102
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic activity of the lantibiotic MU1140.
Ghobrial OG; Derendorf H; Hillman JD
Int J Antimicrob Agents; 2009 Jan; 33(1):70-4. PubMed ID: 18835136
[TBL] [Abstract][Full Text] [Related]
7. Purification and characteristics of a novel bacteriocin produced by Enterococcus faecalis L11 isolated from Chinese traditional fermented cucumber.
Gao Y; Li B; Li D; Zhang L
Biotechnol Lett; 2016 May; 38(5):871-6. PubMed ID: 26875092
[TBL] [Abstract][Full Text] [Related]
8. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential.
McAuliffe O; Ryan MP; Ross RP; Hill C; Breeuwer P; Abee T
Appl Environ Microbiol; 1998 Feb; 64(2):439-45. PubMed ID: 9464377
[TBL] [Abstract][Full Text] [Related]
9. A lacticin 3147 enriched food ingredient reduces Streptococcus mutans isolated from the human oral cavity in saliva.
O'Connor EB; O'Riordan B; Morgan SM; Whelton H; O'Mullane DM; Ross RP; Hill C
J Appl Microbiol; 2006 Jun; 100(6):1251-60. PubMed ID: 16696672
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
Sparo MD; Jones DG; Sánchez Bruni SF
Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
[TBL] [Abstract][Full Text] [Related]
11. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
12. Production of a nisin-like bacteriocin by Lactococcus lactis subsp. lactis A164 isolated from Kimchi.
Choi HJ; Cheigh CI; Kim SB; Pyun YR
J Appl Microbiol; 2000 Apr; 88(4):563-71. PubMed ID: 10792514
[TBL] [Abstract][Full Text] [Related]
13. Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
Morgan SM; O'connor PM; Cotter PD; Ross RP; Hill C
Antimicrob Agents Chemother; 2005 Jul; 49(7):2606-11. PubMed ID: 15980326
[TBL] [Abstract][Full Text] [Related]
14. Nisin Z and lacticin 3147 improve efficacy of antibiotics against clinically significant bacteria.
Ellis JC; Ross RP; Hill C
Future Microbiol; 2019 Dec; 14():1573-1587. PubMed ID: 32019322
[No Abstract] [Full Text] [Related]
15. An effective lacticin biopreservative in fresh pork sausage.
Scannell AG; Ross RP; Hill C; Arendt EK
J Food Prot; 2000 Mar; 63(3):370-5. PubMed ID: 10716567
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
Chi H; Holo H
Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous bacteriocin resistance in Listeria monocytogenes as a susceptibility screen for identifying different mechanisms of resistance and modes of action by bacteriocins of lactic acid bacteria.
Macwana S; Muriana PM
J Microbiol Methods; 2012 Jan; 88(1):7-13. PubMed ID: 22001443
[TBL] [Abstract][Full Text] [Related]
18. Development of bioactive food packaging materials using immobilised bacteriocins lacticin 3147 and nisaplin.
Scannell AG; Hill C; Ross RP; Marx S; Hartmeier W; Elke ; Arendt K
Int J Food Microbiol; 2000 Sep; 60(2-3):241-9. PubMed ID: 11016613
[TBL] [Abstract][Full Text] [Related]
19. Elevated enzyme release from lactococcal starter cultures on exposure to the lantibiotic lacticin 481, produced by Lactococcus lactis DPC5552.
O'Sullivan L; Morgan SM; Ross RP; Hill C
J Dairy Sci; 2002 Sep; 85(9):2130-40. PubMed ID: 12362444
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a 3944 Da bacteriocin, produced by Enterococcus mundtii ST15, with activity against Gram-positive and Gram-negative bacteria.
De Kwaadsteniet M; Todorov SD; Knoetze H; Dicks LM
Int J Food Microbiol; 2005 Dec; 105(3):433-44. PubMed ID: 16102864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
